Product Information

ERYTHROMYCIN DR 250 MG TABLET is a generic product labeled by Torrent Pharmaceuticals Limited, priced at $2.0349 per EA under NDC 13668058601. Its NADAC has been published 264 times since Nov 3, 2021.

FDA first approved this application on Jul 26, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ERYTHROMYCIN DR 250 MG TABLET

ERYTHROMYCIN
$2.0349per EA

Strength

250 mg/1

NDC

13668058601

Classification

Generic

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ERYTHROMYCIN

Approval Type

Generic (ANDA)

FDA Application

ANDA211975

FDA Approved

7/26/2021

TE Code

AB

On Market Since

7/26/2021

Pharmacological Classes

Decreased Sebaceous Gland Activity
Macrolide Antimicrobial
Macrolide
Macrolides

Price Statistics

The NADAC for ERYTHROMYCIN DR 250 MG TABLET has been published 264 times since Nov 3, 2021, and over the history we have for it it has declined 55.3%. The table below summarizes its recorded NADAC range and movement.

Current price$2.0349 per EA
All-time high$5.1930 (Feb 16, 2022)
All-time low$1.6915 (Feb 18, 2026)
52-week high$2.4837
52-week low$1.6915
Median price$3.0424
Average price$3.2562
Largest weekly change+41.1% (Mar 22, 2023)
Weeks tracked264
Tracking sinceNov 3, 2021

Price History

1W

+8.3%

1M

+5.7%

3M

-2.4%

6M

-15.2%

1Y

-4.5%

3Y

-51.4%

5Y

-60.8%

All

-55.3%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ERYTHROMYCIN DR 250 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN DR 250 MG TABLET, manufactured by Torrent Pharmaceuticals Limited, is $2.0349 per EA (NDC 13668058601), effective Nov 18, 2026.

How has the price of ERYTHROMYCIN DR 250 MG TABLET changed over time?

Over the history we have for it, the NADAC for ERYTHROMYCIN DR 250 MG TABLET has declined 55.3%. It has been tracked across 264 weekly CMS publications since Nov 3, 2021.

What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN DR 250 MG TABLET?

Since Nov 3, 2021, the NADAC for ERYTHROMYCIN DR 250 MG TABLET has ranged from a low of $1.6915 (Feb 18, 2026) to a high of $5.1930 (Feb 16, 2022), with a median of $3.0424 per EA.

Are there cheaper alternatives to ERYTHROMYCIN DR 250 MG TABLET?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ERYTHROMYCIN 250 MG TABLET, is $1.8452 per EA — about 9% below ERYTHROMYCIN DR 250 MG TABLET.

Who manufactures ERYTHROMYCIN DR 250 MG TABLET?

ERYTHROMYCIN DR 250 MG TABLET (NDC 13668058601) is labeled by Torrent Pharmaceuticals Limited, and CMS classifies it as a generic product.